Allergy Therapeutics moves ahead with peanut and grass pollen allergy trials
Allergy Therapeutics has announced the first subject has been dosed in the pivotal phase III…
Allergy Therapeutics has announced the first subject has been dosed in the pivotal phase III…
Allergy Therapeutics has revealed that its immunotherapy for birch pollen allergy did not result in…
British biotech Allergy Therapeutics reports positive early-stage results for its house dust mite immunotherapy. It’s…
Allergy Therapeutics has obtained positive Phase II results for its grass pollen allergy vaccine and…
Allergy Therapeutics' vaccine against hayfever has received approval to begin a trial to determine its…
Allergy Therapeutics, a UK-based biotech company, just announced the approval of its clinical trial application…
Bencard Allergie is developing ultra-short course allergy immunotherapies, backed by a strong growth in its…
Allergy Therapeutics has gotten positive results for its phase II trial for birch pollen allergy…